Global Rheumatoid Arthritis Drug Market Size, Share and Trends Analysis Report, By Product Type (Biologics, And Non-Biologics), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, And Online Pharmacy), Forecast (2022-2028)

The global rheumatoid arthritis drugs market is anticipated to grow at a significant CAGR 2% during the forecast period (2022-2028). The increasing prevalence of arthritis and other joint problems creating demand for its treatment which in turn driving the global rheumatoid arthritis drug market. In addition, advances in biosimilar and novel biologics are expected to open the way for new opportunities in the industry and according to the NCBI analysis, the International rheumatoid arthritis drug Industry is expected to improve during the forecast period.

The increasing awareness regarding these drugs, growing obese population, and an increase in the use of rheumatoid arthritis drugs as a first-line treatment for rheumatoid arthritis are major contributors to the market growth. GlaxoSmithKline plc, Sanofi SA, Pfizer Inc., and Cipla Inc. are the key market players that are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches. For instance, in April 2019, Cipla Ltd. gain 30% of the Standard in Branded for Business Expansion of South Africa and the acquisition is designed to integrate the company’s strengths with Brandmed’s new approach, which focuses on patient health care, which will enhance Cipla Medpro’s portfolio and rheumatoid arthritis drugs market.

Market Report

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Product Type
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape-Merck & Co., Inc., GlaxoSmithKline plc, Sanofi SA, Pfizer Inc., and Cipla Inc. Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Rheumatoid Arthritis Drug Market Report by Segment

By Type

• Capsule
• Tablet
• Oral Solution

By Application

• Epilepsy
• Neuropathic Pain
• Restless Legs Syndrome

Global Rheumatoid Arthritis Drug Market Report by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa